Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro. - Wikidata - awgldk - TriplyDB

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

http://www.wikidata.org/entity/Q42277109

about

Hepatitis B virus infection: An insight into infection outcomes and recent treatment options Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection Chronic hepatitis B: A wave of new therapies on the horizon.Future therapy for hepatitis B virus infection.Treatment of hepatitis B virus: an update.Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.New horizon for radical cure of chronic hepatitis B virus infection.Recent advances in managing hepatitis D Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses.Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Activity of nucleic acid polymers in rodent models of HBV infection.Drugs in Development for Hepatitis B.

P2860

Q26782127-9BDD0BEC-A727-44FB-A070-3BC9565FEF81 Q33821878-8159354E-A89A-4E7D-B010-8219DC16BA49 Q35839139-1C32AAD4-4BE7-4F74-87A5-A5A0179395E7 Q36039553-7E721D2A-E0AA-42E8-99E7-9192B4B85776 Q38538107-325AB860-896D-4E8E-9E64-B565FA0AD710 Q38565056-9F1E6DB3-E713-4DE3-A5B0-0A35D87E526F Q38794446-5D1FB3EF-28FF-4087-84D7-E64E59D99521 Q39368000-5C822D69-ACD4-4CF2-AEC1-FA2CBEB1B420 Q40302798-BC5FB3D9-BA24-4022-AC5A-CFC07AFA6948 Q40593364-25FD55E1-E4C4-4CEC-8A2F-40979F6C3E9A Q41588940-B3F42A83-C75B-4262-855B-5954FE170D47 Q41930666-C8F9FBAA-B2F4-4CD3-83F2-95600A5CCDBF Q42207445-4CD6B7D0-87BA-42EA-9BD3-928D61406356 Q45323707-C9FCDD3E-F76C-4CC4-B3FC-C3E963115D52 Q46263692-C9CE1CC6-0416-428A-8F0B-AC27B997B533 Q52764230-5117DCD2-87B1-4F44-B2A0-7847A26B5D02

P2860

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

http://www.wikidata.org/entity/Q42277109

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

@en

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

@nl

type

label

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

@en

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

@nl

prefLabel

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

@en

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.

@nl

P1433

Q42277109-28802430-6078-4036-8C72-F2AF4E9B9C8F

P1476

Q42277109-16B49EED-2A7E-40B3-BC4B-B18DF0D596D4

P2093

Q42277109-3051E607-5D17-4A5F-B971-AC7F79D54ED3

Q42277109-A5447C6C-B7D3-448D-918E-AE7D90C34A81

P2860

Q42277109-0285383C-8ED0-4479-9049-D6ED9D656A02

Q42277109-117EF910-E3B2-45FF-8597-F2BC1EF63DE3

Q42277109-1290CC3B-4963-4A26-97B5-A2D7D0091F22

Q42277109-13B7EC30-7DB5-470C-8E3A-E8D6814A5224

Q42277109-1FC8668D-E4F9-495D-9483-51EEA05AEC87

Q42277109-27B97E7B-50BE-4A87-A72C-574C9178DDA1

Q42277109-2F0B6FD2-946A-4FC2-BFB1-BD0DFD8CDF2B

Q42277109-3F60A779-9D05-4965-826F-2CAE0A04858F

Q42277109-45C6B09D-7601-42F0-B919-FD4A7BFB08A9

Q42277109-5196258E-9C6B-4ADD-A5FE-F38A4B36FB0B

P304

Q42277109-220422EF-22EA-4B67-851A-DE75C78F6BB4

P31

Q42277109-D574A062-1425-437A-B929-7E79C24BD900

P356

Q42277109-4EA49974-8F11-4604-B4C2-9E9F8D6F63B9

P407

Q42277109-7022FCE2-2E75-400A-8A86-816677249D88

P433

Q42277109-11B75E4E-0159-4DB8-BA13-3E6D40EBEAF7

P478

Q42277109-777771AE-525D-4F5B-B345-2F8888F5F7C5

P50

Q42277109-709D4962-007F-4A14-A555-AC5B3FC9AD74

P577

Q42277109-39AB587D-A956-459A-A44D-9A9623A07112

P698

Q42277109-9A91DF8E-40EB-4682-A8DF-626C025E5F32

P932

Q42277109-7A83486D-146A-4F49-A764-84A091308924

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro

@en

P2093

Andrew Vaillant

http://www.w3.org/2001/XMLSchema#string

Faseeha Noordeen

http://www.w3.org/2001/XMLSchema#string

P2860

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins

Inhibition of cellular entry of lymphocytic choriomeningitis virus by amphipathic DNA polymers

Initiation of duck hepatitis B virus infection requires cleavage by a furin-like protease

Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides.

Drug properties of second-generation antisense oligonucleotides: how do they measure up to their predecessors?

Evidence for intramolecularly folded i-DNA structures in biologically relevant CCC-repeat sequences.

Susceptibility to duck hepatitis B virus infection is associated with the presence of cell surface receptor sites that efficiently bind viral particles.

Duck hepatitis B virus: an invaluable model system for HBV infection.

Review article: Nucleoside analogues for the treatment of chronic hepatitis B.

P304

5291-5298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01003-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Allison R Jilbert

P577

2013-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23939902

http://www.w3.org/2001/XMLSchema#string

P932

3811297

http://www.w3.org/2001/XMLSchema#string